An OHSU study finds that state-level abortion bans were associated with a reduction in evidence-based medical care for miscarriage management. Maria Rodriguez, M.D., says, “Patients are having to wait longer to receive treatment, and when they arrive, they have fewer choices. These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually.”

OHSU researchers have discovered that a protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA — a discovery that could lead to new strategies to make chemotherapy and other DNA-damaging therapies more effective. Rosalie Sears, Ph.D., says, “Our work shows that MYC isn’t just helping cancer cells grow — it’s also helping them survive some of the very treatments designed to kill them.”

An OHSU study finds that state-level abortion bans were associated with a reduction in evidence-based medical care for miscarriage management. Maria Rodriguez, M.D., says, “Patients are having to wait longer to receive treatment, and when they arrive, they have fewer choices. These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually.”

An OHSU study finds that state-level abortion bans were associated with a reduction in evidence-based medical care for miscarriage management. Maria Rodriguez, M.D., says, “Patients are having to wait longer to receive treatment, and when they arrive, they have fewer choices. These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually”

An OHSU study finds that state-level abortion bans were associated with a reduction in evidence-based medical care for miscarriage management. Maria Rodriguez, M.D., says, “Patients are having to wait longer to receive treatment, and when they arrive, they have fewer choices. These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually.”

Media cover a unique Oregon law that allows blocking of healthcare deals, which has not been nearly as effective as many experts hoped. Jane Zhu, M.D., says, “They don’t necessarily change the equation when it comes to the trend toward consolidation … regulators can approve the merger and prices go up and consolidation worsens, or they can block a merger and maybe there’s an immediate effect on the clinic’s solvency or sustainability.”

OHSU researchers have discovered that a protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA — a discovery that could lead to new strategies to make chemotherapy and other DNA-damaging therapies more effective. Rosalie Sears, Ph.D., says, “Our work shows that MYC isn’t just helping cancer cells grow — it’s also helping them survive some of the very treatments designed to kill them.”

Earth.com reports on an OHSU study that found serotonin may amplify signals in the brain’s hearing system, worsening tinnitus symptoms.

OHSU researchers have discovered that a protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA — a discovery that could lead to new strategies to make chemotherapy and other DNA-damaging therapies more effective. Rosalie Sears, Ph.D., says, “Our work shows that MYC isn’t just helping cancer cells grow — it’s also helping them survive some of the very treatments designed to kill them.”

The Oregonian mentions Phil and Penny Knight's $2 billion pledge to the OHSU’ Knight Cancer Institute in a story about a new $90 million gift from the Knights to Stanford University for research into brain resilience and aging.